Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Reardon

Showing results (81-90 of 404) with videos related to

Pageof 41
Sort By:
Neuro-Oncology|November 1, 2014
Medical management of brain tumors and the sequelae of treatmentDavid Schiff, Eudocia Q Lee, Lakshmi Nayak, et al.
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.
The Lancet. Oncology|February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careDebashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Cancer|May 24, 2007
Molecularly targeted therapy for malignant gliomaSith Sathornsumetee, David A Reardon, Annick Desjardins, et al.
Nature Reviews. Neurology|May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyondMichael Weller, Patrick Roth, Matthias Preusser, et al.
Journal of Neuro-Oncology|June 5, 2010
Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapyKatherine B Peters, Thomas E Coyle, James J Vredenburgh, et al.
Survey of Ophthalmology|March 5, 2011
Knee deep in the nerveLuciano M Simao, Eman Nasr El Dine Sultan, Jennifer K Hall, et al.
Expert Opinion on Biological Therapy|September 1, 2004
Monoclonal antibodies for brain tumour treatmentAbraham Boskovitz, Carol J Wikstrand, Chien-Tsun Kuan, et al.
Journal of Neuro-Oncology|March 13, 2013
PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussionJ Lee Villano, Patrick Y Wen, Eudocia Q Lee, et al.
Journal of Adolescent and Young Adult Oncology|January 20, 2022
Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer InstituteSupriya Sarvode, Jayne R Vogelzang, Suraj Sarvode Mothi, et al.
Pageof 41

Showing results (81-90 of 404) with videos related to

Sort By:
Pageof 41
Neuro-Oncology|November 1, 2014
Medical management of brain tumors and the sequelae of treatmentDavid Schiff, Eudocia Q Lee, Lakshmi Nayak, et al.
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.
The Lancet. Oncology|February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careDebashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Cancer|May 24, 2007
Molecularly targeted therapy for malignant gliomaSith Sathornsumetee, David A Reardon, Annick Desjardins, et al.
Nature Reviews. Neurology|May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyondMichael Weller, Patrick Roth, Matthias Preusser, et al.
Journal of Neuro-Oncology|June 5, 2010
Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapyKatherine B Peters, Thomas E Coyle, James J Vredenburgh, et al.
Survey of Ophthalmology|March 5, 2011
Knee deep in the nerveLuciano M Simao, Eman Nasr El Dine Sultan, Jennifer K Hall, et al.
Expert Opinion on Biological Therapy|September 1, 2004
Monoclonal antibodies for brain tumour treatmentAbraham Boskovitz, Carol J Wikstrand, Chien-Tsun Kuan, et al.
Journal of Neuro-Oncology|March 13, 2013
PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussionJ Lee Villano, Patrick Y Wen, Eudocia Q Lee, et al.
Journal of Adolescent and Young Adult Oncology|January 20, 2022
Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer InstituteSupriya Sarvode, Jayne R Vogelzang, Suraj Sarvode Mothi, et al.
Pageof 41